We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AKLI

Price
-
Stock movement up
+- (%)
Company name
Akili Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Health Information Services
Market cap
34.01M
Ent value
-12.17M
Price/Sales
17.46
Price/Book
0.68
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-61.08%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2024-12-16

DIVIDENDS

AKLI does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales17.46
Price to Book0.68
EV to Sales-6.25

FINANCIALS

Per share

Loading...
Per share data
Current share count78.73M
EPS (TTM)-0.62
FCF per share (TTM)-0.63

Income statement

Loading...
Income statement data
Revenue (TTM)1.95M
Gross profit (TTM)1.09M
Operating income (TTM)-56.23M
Net income (TTM)-48.55M
EPS (TTM)-0.62
EPS (1y forward)-0.46

Margins

Loading...
Margins data
Gross margin (TTM)56.11%
Operating margin (TTM)-2886.60%
Profit margin (TTM)-2492.04%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash63.34M
Net receivables144.00K
Total current assets65.00M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment2.28M
Total assets67.36M
Accounts payable1.10M
Short/Current long term debt13.59M
Total current liabilities11.21M
Total liabilities17.16M
Shareholder's equity50.21M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-48.77M
Capital expenditures (TTM)370.00K
Free cash flow (TTM)-49.13M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-96.69%
Return on Assets-72.06%
Return on Invested Capital-77.96%
Cash Return on Invested Capital-78.90%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
AKLIS&P500
Current price drop from All-time high-96.93%-
Highest price drop-98.48%-56.47%
Date of highest drop17 Apr 20249 Mar 2009
Avg drop from high-91.12%-11.07%
Avg time to new high237 days12 days
Max time to new high469 days1805 days
COMPANY DETAILS
AKLI (Akili Inc) company logo
Marketcap
34.01M
Marketcap category
Small-cap
Description
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts. As of July 1, 2024, Akili, Inc. operates as a subsidiary of Virtual Therapeutics Corp.
Employees
68
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner